Navigation Links
Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management
Date:6/17/2008

o be joining this dynamic team," Ms. Kolb added.

The clinical operations team at PROMETRIKA provides research planning and execution services to support product development in pharmaceuticals, biologics and medical devices for companies around the world. Team leaders are responsible for project planning and management, including monitoring enrollment, research schedules, third party vendor management, budgeting and performance metrics. They also coordinate services related to data management, biostatistics and medical writing for data collection and analysis, internal and external reporting, and regulatory filings.

According to a research study by CMSInfo, spending on clinical trials in the United States reached $24 billion in 2005, and it is projected to rise to $32.1 billion by 2011. The Congressional Budget Office in the United States estimates that by 2003 the average cost to develop a drug that represents a new molecular entity (NME) reached $802 million and the development timeline for NME drugs required an average of 7.5 years of clinical stage research.

"Increasingly, clients are looking to us for new approaches involving electronic data capture and other technologies that can maximize research efficiency without compromising quality and accuracy. With Faith's experience in these areas, PROMETRIKA is better prepared than ever before to be a comprehensive resource to help our clients plan and execute strategic and successful clinical research programs," Ms. Stepanians added.

About PROMETRIKA

Founded in 2003, PROMETRIKA, LLC, is a full service contract research organization with headquarters in Cambridge, MA. The company provides a full range of clinical research services to pharmaceutical, biotechnology and medical device companies. PROMETRIKA's team has managed hundreds of clinical trials from Phase 1 pharmacokinetic crossover trials to Phase 4 long-term multi-center studies. The company has extensive experience in all area
'/>"/>

SOURCE PROMETRIKA, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... RARITAN, N.J. , May 30, 2015 ... single-arm Phase 2 MMY2002 (SIRIUS) trial show treatment ... monoclonal antibody – achieved an overall response rate ... assessed by an independent review committee, in heavily ... consistent among the pre-specified subgroups based on age, ...
(Date:5/29/2015)... Los Gatos, CA (PRWEB) May 29, 2015 ... diagnostics company addressing multi-drug-resistant organisms (MDROs), announced that ... technology for same-shift bacterial detection and susceptibility testing ... asm2015 on May 31, 2015 in ... a new class of molecular diagnostics that can ...
(Date:5/29/2015)... Columbia, Pa. (PRWEB) May 29, 2015 ... Thermal Product Solutions with a request to design ... remove excess moisture from prescription medications being produced ... custom solution that includes a robotic gantry, heat-saving ... positions and dries trays of 3D-printed pills to ...
(Date:5/29/2015)... Results from a Phase III clinical trial examining ... reduce the size of melanoma tumors in patients injected ... of Clinical Oncology. , The global, randomized trial ... melanoma, a potentially fatal form of skin cancer. The ... safety and efficacy of the oncolytic virus immunotherapy compared ...
Breaking Biology Technology:Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 2Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 3New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2
... GRAND RAPIDS, Mich., May 20 The West ... it has been selected to review and approve ... the Michigan Pre-Seed Capital Fund. The Michigan ... to support high-tech, high-growth start-up companies in four ...
... May 20 deCODE genetics,(Nasdaq: DCGN ... isolation and,genotyping laboratory, which processes the company,s ... tests for several common,diseases, has been accredited ... a recent inspection. The U.S. Centers for ...
... Launch into High Growth Brazilian Market for Aesthetic ... announced today the receipt of ANVISA clearance to ... in Brazil. ANVISA (Agencia Nacional de Vigilancia ... regulatory agency charged with clearing all applications to ...
Cached Biology Technology:The West Michigan Science & Technology Initiative is Named Statewide Reviewer for Life Science Funding Requests Through New Program 2The West Michigan Science & Technology Initiative is Named Statewide Reviewer for Life Science Funding Requests Through New Program 3deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation 2deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation 3deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation 4Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil 2Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil 3
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/22/2015)... 2015 According to a new ... 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware ... Consumer and Home) - Global Forecast to 2020", published ... Billion in 2015 to $6.19 Billion by 2020, at ... market data Tables and   43 Figures spread through ...
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. ... that its wholly owned subsidiary, 3D-ID LLC, a company ... Team Battelle for the biometrics technology portion of the ... Contract from the Department of the Army. ... products developed for government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... the Gulf of Mexico could soon catch the oil slick ... Keys, scientists are monitoring the situation closely with ESA,s Envisat ... information with Envisat Advanced Synthetic Aperture Radar (ASAR) data of ... direction in which the spill boundaries can drift. ,In these ...
... Arabinoxylan, the major dietary fibre component of wheat ... point of view. New enzymatic technologies were developed in ... The results offer potential for a new soluble fibre ... of cereal fibre, in particular in the prevention of ...
... A wide range of gluten free cereals have been ... of the European Union, and their impact on product ... as high-pressure processing technology have been successfully applied to ... free cereal products. In genetically susceptible individuals, the ...
Cached Biology News:Envisat monitors oil spill proximity to Loop Current 2New and improved gluten-free foods developed for patients with celiac disease 2